REVOLUTION PHARMD...

The purpose of this site is to bring a revolution in health care profession by spreading knowledge relating to Pharm.D.To improve quality of Pharm.D education.

Reiciendis voluptatibus maiores

REVOLUTION PHARMD

The purpose of this site is to bring a revolution in health care profession by spreading knowledge relating to Pharm.D.To improve quality of Pharm.D education

Voluptates repudiandae sint

REVOLUTION PHARMD.

Have a peace of mind that your notes will always be there when you need them.

Omnis dolor repellendus

REVOLUTIONIZNING THE HEALTH CARE

The purpose of this site is to bring a revolution in health care profession by spreading knowledge relating to Pharm.D.To improve quality of Pharm.D education.

Pomnis voluptas assumenda

REVOLUTION PHARMD

Have a peace of mind that your notes will always be there when you need them..

Harum quidem rerum

REVOLUTION PHARMD

The purpose of this site is to bring a revolution in health care profession by spreading knowledge relating to Pharm.D.To improve quality of Pharm.D education.

Harum quidem rerum
  • Reiciendis voluptatibus maiores
  • revolutionizng
  • Voluptates repudiandae sint
  • Necessitatibus saepe eveniet
  • Omnis dolor repellendus
  • Pomnis voluptas assumenda
  • Harum quidem rerum

Workshop on "Emerging Role of Pharmacists in Health Management"at AIIMS

Registration Fees: Rs.3000/‐ (limited seats only)
                             Rs.1500/-  For Students  

DPA owes to fight against strike call on March 28 by drug trade organisations


APSCHE says not to collect fee during Pharm.D internship

The Government of  Andhra Pradesh has responded to the representation of  Pharm.D 1st batch students.The  students have represented to the Government of A.P. requesting Not to collect tution fees in Pharma-D courses to undergo clinical Internship/Residency training and more particularly provide stipend to the students on the lines of MBBS/BDS - Reg.

The Department of Higher Education had written to  the Secretary APSCHE(Andhra Pradesh State Council of Higher Education) on 18.01.2014 for taking further action in this regard as per rules. The secretary APSCHE  had submitted their remarks to the government with their findings vide Letter:Rc.No.165/APSCHE/ Pharma-D/ clinicalInternship/Residency on Dt: 28.01.2014.

The Secretary APSCHE submitted to the Government that:

JNTU-HYD : Pharm.D III,IV,V Years Regular/Supple Examination Notifications (April/May 2014)

PHARM D – III , IV , V YEAR SUPPLEMENTARY EXAMINATIONS

CANDIDATES APPEARING FOR THE ABOVE EXAMINATIONS COMMENCING FROM 5th MAY 2014 ARE INFORMED THAT THE APPLICATIONS WILL BE RECEIVED AS PER THE TIME SCHEDULE GIVEN BELOW:

WITHOUT LATE FEE : 01-04-2014
WITH LATE FEE OF RS.100/- : 03-04-2014
WITH LATE FEE OF RS.1000/- : 07-04-2014

Potential of Pharm D graduates to be utilized for success of PvPI: Dr Gupta

Tuesday, March 04, 2014, 08:00 Hrs  [IST]
While agreeing that the great potential of the Pharm D graduates will be a supporting asset for the pharmacovigilance programme of India (PvPI), the national scientific coordinator of the programme, Dr Yogendra Kumar Gupta said the highly qualified pharmacists will be absorbed into it for the success of the ADR reporting.

“I think the Pharm D graduates will have better understanding, sufficient time, and most importantly they can think of building careers in medicine safety. So, to ensure continuous interest of graduates of Pharm D in the PvPI, and for the growth of the programme, we must create better job opportunities, career growth/ promotional avenues and higher level positions,” Dr Gupta told Pharmabiz.

According to him, ADR reporting requires high degree of motivation. The culture of ADR reporting in doctors in the country has just started and yet to mature. Busy schedule, lack of time, lack of incentives, fear of adverse publicity and lack of understanding as to what to report, where to report and how to do causality assessment, etc. are the bottlenecks in reporting by the doctors.

Pharm D graduates should be roped in for ADR monitoring for success of PvPI: Experts

Saturday, March 01, 2014, 08:00 Hrs  [IST]
Even as the pharmacovigilance programme of India (PvPI), launched by the Union health ministry, is fast improving with reporting of adverse drug reactions from various places in the country, the academicians and experts in pharmacy practice argue that the task of monitoring ADRs should be entrusted with the Pharm D graduates for the success of the programme.


According to sources, after completing the six-year course, 300 Pharm D graduates will come out in three months out of 10 colleges in the country. They are all well-trained in pharmacovigilance, hence their potential should be utilized for the proper management of the healthcare of the people.

According to Dr Gopal Veni, principal of the College of Pharmacy, Mother Teresa Institute of Health Sciences, Pondicherry, the Pharmacovigilance programme must be a team work of doctors and qualified pharmacists.

PCI Curriculum Committee to update Pharm D syllabus to keep pace with new developments

Monday, February 24, 2014, 08:00 Hrs  [IST]
Pharmacy Council of India (PCI) is now working to update the Pharm D syllabus in an effort to ensure the subjects are current in content going by the fast paced developments in the area of newer drugs and novel methods of administration.


In this regard the Curriculum Committee of the PCI  has seen the need to either introduce new subjects or revise the topics in the course. Updation and keeping a pulse of all action not just in the industry but in the area of research, marketing and drug dispensing in a hospital environment is the need of the hour. “We have envisaged that the only advisor to the doctor in the  health care space would be a pharmacist which brought us to introduce the Pharm D course in 2008.  There is a visible consensus on the need to upgrade the curriculum”, Dr B Suresh,  president, Pharmacy Council of India and vice chancellor, JSS University Mysore told Pharmabiz in an interaction.

“The Pharm D syllabus need to be advanced, keeping in perspective the challenging scenario of healthcare industry and we are working to provide an updated syllabus for this coming academic year”, he said.

Indian Congress of Pharmacy Practice 2014 Concludes

    Sunday, February 23, 2014

Inaugural Convention of the Indian Association of Colleges of Pharmacy & Indian Congress of Pharmacy Practice 2014,concluded at Hotel Sheraton,Bengaluru on Friday.Students, academicians, professionals and administrators from pharma industry and hospitals have attended the two days programme. Leaders  in pharmacy practice and education from USA, Australia, UK, Southeast Asia, Middle East and Europe have Participated in the conference and delivered their talks and interacted with the new breed of pharmacists (Pharm.D).

300 Pharm D graduates to pass out from 10 colleges this year, 100% placements expected

Nandita Vijay, BengaluruSaturday, February 22, 2014, 08:00 Hrs  [IST]
The six year Pharm D course will now bring to the fore within three months, 300 qualified graduates passing out of 10 colleges in the country.  The Pharmacy Council of India (PCI) and the Indian Association of Colleges of Pharmacy (IACP) have  ensured that the spotlights are on the first batch of these 300 candidates. It is making certain that healthcare providers and the clinical research organizations (CRO) would assess the expertise of these candidates well ahead of the campus interviews.

“We are doing every bit to ensure that all  300 students are suitably employed. The hospitals and the CROs will soon realize their indispensability, Dr K Chinnasamy Professor Emeritus, JSS College of Pharmacy Ootacamund and president, Indian Congress of Pharmacy Practice 2014 told Pharmabiz.

There are over 20,000 hospitals in India with 10 of which are Joint Commission International accredited and over 70 National Accreditation Board for Healthcare & Hospital Providers (NABH) certified hospitals in India. In addition, there is a huge presence of 400 medical colleges, multinational companies and  corporate healthcare providers established in the country and many more new facilities coming up to cater to the treatments needs of its 1.2 billion population.